SupSta B TB Indicators 22FEB2016_OMB_DGMQ

SupSta B TB Indicators 22FEB2016_OMB_DGMQ.docx

Information Collection for Tuberculosis Data from Panel Physicians

OMB: 0920-1102

Document [docx]
Download: docx | pdf

Information Collection for Tuberculosis Data from Panel Physicians


Request for renewal of an Existing Data Collection Device without an OMB Number


OMB No. 0920-XXXX




July 10, 2015

Statement B


















Contact:

Amy McMillen

Office of Policy and Planning

National Center for Emerging and Zoonotic Infectious Diseases

Centers for Disease Control and Prevention

1600 Clifton Road, N.E., MS C-12

Atlanta, Georgia 30333

Phone: (404) 639-1045

Fax: (404) 248-4146

Email: [email protected]










Table of Contents


  1. Respondent Universe and Sampling Methods p. 3

  2. Procedures for the Collection of Information p. 3

  3. Methods to Maximize Response Rates and Deal with No Response p. 3

  4. Tests of Procedures or Methods to be Undertaken p. 3

  5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data p. 3




B. Collections of Information Employing Statistical Methods


This information collection does not involve statistical methods.


  1. Respondent Universe and Sampling Methods


The respondents are all Panel Physicians. These are medically trained, licensed, and experienced medical doctors practicing overseas who are appointed by the local US embassy or consulate to perform medical examinations for prospective immigrants to the United States. More than 760 panel physicians at 353 panel sites perform overseas pre-departure medical examinations in accordance with requirements, referred to as Technical Instructions, provided by the Centers for Disease Control and Prevention’s Division of Global Migration and Quarantine, Quality Assessment Program (QAP).


TB Indicator data is collected in aggregate and does not contain individual level data related to geographic, demographic or socioeconomic characteristics. Because TB Indicator data is not obtained from a national surveillance system, it is representative only of TB incidence rates among U.S. migrant populations, which may or may not be representative of the general population of each country. TB Indicator data represents TB incidence in U.S. migrant populations. As such, it may or may not be representative of the country’s populations in a way likely to correlate with social, demographic, and geographic characteristics that influence vulnerability to disease. Thus, whenever the data are used for epidemiologic purposes, CDC will compare the characteristics of the population covered in the data base to the characteristics of the population to whom they intend to generalize, and clearly caveat the likelihood of over or under-estimates of TB burden.



2. Procedures for the Collection of Information


As part of the immigration medical exam performed under existing federal regulations, panel physicians perform chest x-ray and laboratory tests that are used to diagnose tuberculosis. CDC is requesting that panel physicians report this data in aggregate using a Microsoft Excel spreadsheet at the end of each calendar year. CDC will send all panel sites the Excel file by email and request all submissions to be completed and returned to CDC by email.


3. Methods to Maximize Response Rates and Deal with No Response


CDC will follow-up with any panel site that does not submit data and request the data up to two additional times. Sites with no response after three attempts will be considered ‘incomplete’ and will not be included in any analyses or reports.


4. Tests of Procedures or Methods to be Undertaken


CDC collected pilot TB indicator data in 2013 by sending the data collection tool (Excel spreadsheet) to all panel sites globally (N=315) and received data from 252 sites (80%). Panel physicians reported screening 536,531 applicants in 2013; 4% with chest radiographs suggestive of TB. A total of 1,345 applicants were diagnosed with TB disease (251per 100,000), including 784 (72%) with smear negative/culture positive disease.


5. Individuals Consulted on Statistical Aspects and Individuals Collecting and/or Analyzing Data


No statistical methods are employed in this information collection.

4


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File Modified0000-00-00
File Created2021-01-21

© 2024 OMB.report | Privacy Policy